Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN): A Double-Blind, Randomized, Placebo-Controlled Study

2006 ◽  
Vol 47 (5) ◽  
pp. 751-760 ◽  
Author(s):  
Philip Kam-Tao Li ◽  
Chi Bon Leung ◽  
Kai Ming Chow ◽  
Yuk Lun Cheng ◽  
Samuel Ka-Shun Fung ◽  
...  
Keyword(s):  
Hong Kong ◽  
Iga Nephropathy ◽  
Controlled Study ◽  
Double Blind

scholarly journals Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind randomized placebo-controlled study

2004 ◽  
Vol 6 (2) ◽  
pp. A7
Author(s):  
P.K.T. Li ◽  
C.B. Leung ◽  
K.M. Chow ◽  
Y.L. Cheng ◽  
S.K. Fung ◽  
...  
Keyword(s):  
Hong Kong ◽  
Iga Nephropathy ◽  
Controlled Study ◽  
Double Blind

scholarly journals POS-380 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (THE ALIGN STUDY)

2021 ◽  
Vol 6 (4) ◽  
pp. S164-S165
Author(s):  
H. Lambers Heerspink ◽  
D. Kohan ◽  
R. Lafayette ◽  
A. Levin ◽  
H. Zhang ◽  
...  
Keyword(s):  
Iga Nephropathy ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study

2003 ◽  
Vol 18 (10) ◽  
pp. 1015-1019 ◽  
Author(s):  
James C. M. Chan ◽  
John D. Mahan ◽  
Howard Trachtman ◽  
Jon Scheinman ◽  
Joseph T. Flynn ◽  
...  
Keyword(s):  
Vitamin E ◽  
Iga Nephropathy ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document